TransMedics Group, Inc. Research And Development Expense

• TransMedics Group, Inc. showed an increase of +23.4% in Research And Development Expense from 2024 to 2025.
• This data is from TransMedics Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), TransMedics Group, Inc.'s Research And Development Expense has grown by 405.7%.
• Historical annual values: Fiscal year 2025: $69.06 million | Fiscal year 2024: $55.97 million | Fiscal year 2023: $36.06 million | Fiscal year 2022: $26.81 million | Fiscal year 2021: $22.30 million | Fiscal year 2020: $18.83 million | Fiscal year 2019: $19.87 million | Fiscal year 2018: $13.66 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026